Investing for the Future: A Look at Two Growth Stocks

A long-term investment horizon in high-quality companies offers excellent opportunities to build a successful portfolio. Whether you prefer growth-oriented, value-oriented, or dividend-rich stocks, diversification in your investments can help minimize risk and maximize returns. This holds true even for investors ready to start with an amount of 500 euros—small sums can pay off with smart investment decisions. A company currently presenting itself as a strong growth option is Eli Lilly. Enthusiasm for its GLP-1 medications and a strong drug pipeline have allowed the pharmaceutical giant's stock to gain about 57% over the last year. Revenues rose impressively by 36% year over year to $11.3 billion, with the majority of income coming from the drugs Mounjaro, Zepbound, and Verzenio. Net income increased by 68% to nearly $3 billion, highlighting the company's continued growth potential. Another point for investors is the recent approval of Kisunla, a potentially groundbreaking drug for the treatment of Alzheimer's disease, which has shown positive study results. Eli Lilly also offers a promising approach in oncology with Jaypirca, which recently received the green light in Japan. Despite a strong rise in stock, Eli Lilly maintains its tradition of regular dividend payments, making it attractive to long-term investors. Chipotle Mexican Grill is also in investors' focus, despite personnel changes such as CEO Brian Niccol's departure. Through a 50-for-1 stock split in June 2024, the company has made its stock more accessible to a wider audience, leading to a price increase of about 27% this year. Despite economic uncertainties, the demand for Chipotle products remains strong, reflected in an 18% revenue growth in the second quarter of 2024. The company impresses with a solid operating margin and plans to expand with 53 new restaurants, supporting its growth strategy. For investors betting on solid growth potential, an investment in Chipotle could be worthwhile in the long term.